Ars TechnicaCenter·
Moderna's mRNA flu shot earns FDA approval after rollercoaster review
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
Read at Ars Technica →
Technology · 1 sources covering this
Moderna's mRNA flu shot earns FDA approval after rollercoaster review
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/5297734019f410d538277e3cf33c07486c0f66be" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Moderna's mRNA flu shot earns FDA approval after rollercoaster review"></iframe>
